Identification of Subclinical Myocardial Dysfunction in Breast Cancer Patients with Metabolic Syndrome after Cancer-Related Comprehensive Therapy

Table 3

Multivariate analysis for GLS in breast cancer patients with metabolic syndrome after treatment.

Factor	β	SE	value
Age	0.014	0.076	0.855
BMI	−0.222	0.154	0.160
Anthracycline	0.767	1.194	0.525
Trastuzumab	2.489	1.107	0.031
Left-side radiotherapy	0.578	1.077	0.595